» Articles » PMID: 30603630

Clinical Significance of Revised Microscopic Positive Resection Margin Status in Ductal Adenocarcinoma of Pancreatic Head

Overview
Specialty General Surgery
Date 2019 Jan 4
PMID 30603630
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Recent studies have suggested microscopic positive resection margin should be revised according to the presence of tumor cells within 1mm of the margin surface in resected specimens of pancreatic cancer. However, the clinical meaning of this revised margin status for R1 resection margin was not fully clarified.

Methods: From July 2012 to December 2014, the medical records of 194 consecutive patients who underwent pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head were analyzed retrospectively. They were divided into 3 groups on margin status; revised microscopic negative margin (rR0) - tumor exists more than 1 mm from surgical margin, revised microscopic positive margin (rR1) - tumor present within less than 1 mm from surgical margin, classic microscopic positive margin (cR1) - tumor is exposed to surgical margin.

Results: There were 76 rR0 (39.2%), 100 rR1 (51.5%), and 18 cR1 (9.3%). There was significant difference in disease-free survival rates between cR1 . rR1 (8.4 months . 24.0 months, P = 0.013). Margin status correlated with local recurrence rate (17.1% in rR0, 26.0% in rR1, and 44.4% in cR1, P = 0.048). There is significant difference in recurrence at tumor bed (11.8% in rR0 . 23.0 in rR1, P = 0.050). Of rR1, adjuvant treatment was found to be an independent risk factor for local recurrence (hazard ratio, 0.297; 95% confidence interval, 0.127-0.693, P = 0.005).

Conclusion: Revised R1 resection margin (rR1) affects recurrence at the tumor bed. Adjuvant treatment significantly reduced local recurrence of rR1. Accordingly, adjuvant chemoradiation for rR1 group should be taken into account.

Citing Articles

Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis.

Leonhardt C, Niesen W, Kalkum E, Klotz R, Hank T, Buchler M BJS Open. 2022; 6(2).

PMID: 35301513 PMC: 8931487. DOI: 10.1093/bjsopen/zrac010.


Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.

Chopra A, Zenati M, Hogg M, Zeh 3rd H, Bartlett D, Bahary N Ann Surg Oncol. 2021; 28(12):7759-7769.

PMID: 34027585 DOI: 10.1245/s10434-021-10175-y.


Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus.

Kim Y, Shin S, Han I, Ryu Y, Kim N, Choi D Ann Hepatobiliary Pancreat Surg. 2020; 24(3):269-276.

PMID: 32843591 PMC: 7452792. DOI: 10.14701/ahbps.2020.24.3.269.


Three Thousand Consecutive Pancreaticoduodenectomies in a Tertiary Cancer Center: A Retrospective Observational Study.

Jung J, Choi D, Yoon S, Yoon S, Han I, Heo J J Clin Med. 2020; 9(8).

PMID: 32784559 PMC: 7465877. DOI: 10.3390/jcm9082558.


Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.

McIntyre C, Zambirinis C, Pulvirenti A, Chou J, Gonen M, Balachandran V Ann Surg Oncol. 2020; 28(1):539-549.

PMID: 32451945 PMC: 7918294. DOI: 10.1245/s10434-020-08600-9.

References
1.
Sohn T, Yeo C, Cameron J, Koniaris L, Kaushal S, Abrams R . Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2001; 4(6):567-79. DOI: 10.1016/s1091-255x(00)80105-5. View

2.
Bassi C, Stocken D, Olah A, Friess H, Buckels J, Hickey H . Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg. 2005; 22(5):353-63. DOI: 10.1159/000089771. View

3.
Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S . Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006; 10(4):511-8. DOI: 10.1016/j.gassur.2005.09.016. View

4.
Verbeke C, Leitch D, Menon K, McMahon M, Guillou P, Anthoney A . Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006; 93(10):1232-7. DOI: 10.1002/bjs.5397. View

5.
Winter J, Cameron J, Campbell K, Arnold M, Chang D, Coleman J . 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006; 10(9):1199-210. DOI: 10.1016/j.gassur.2006.08.018. View